Senate Republicans seek probe of Mylan EpiPen oversight

Go back to Senate Republicans seek probe of Mylan EpiPen oversight

Mylan (MYL) Gains Ahead of CEO Capitol Hill Testimony

September 21, 2016 10:02 AM EDT

Mylan (NASDAQ: MYL) moving to session highs ahead of CEO Capitol Hill testimony. Shares up 1.36%.

... More